Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus

Journal of General Virology

Volumn 96, Issue 7, 2015, Pages 1651-1663

  Roberts, Kimberly K ^a   Hill, Terence E ^a   Davis, Melissa N ^a   Holbrook, Michael R ^a,b,c   Freiberg, Alexander N ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; PROTEIN P53; STAT2 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; BUNYAVIRUS INFECTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; FEMALE; GENETIC DIFFERENCE; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RIFT VALLEY FEVER VIRUS; TH1 CELL; VIRUS GENE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; C57BL MOUSE; CELL LINE; CHLOROCEBUS AETHIOPS; DOWN REGULATION; GROWTH, DEVELOPMENT AND AGING; IMMUNE EVASION; IMMUNOLOGY; SECRETION (PROCESS); VIROLOGY; VIRULENCE;

BUNYAVIRIDAE; PHLEBOVIRUS; RIFT VALLEY FEVER VIRUS;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOKINES; DOWN-REGULATION; FEMALE; IMMUNE EVASION; MACROPHAGES; MICE, INBRED C57BL; RIFT VALLEY FEVER VIRUS; VIRULENCE;

EID: 84938310591     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.000119     Document Type: Article

References (59)

1. Abdel-Wahab, K. S., El Baz, L. M., El-Tayeb, E. M., Omar, H., Ossman, M. A. & Yasin, W. (1978). Rift Valley fever virus infections in Egypt: pathological and virological findings in man. Trans R Soc Trop Med Hyg 72, 392-396.
2. Al Azraqi, T. A., El Mekki, A. A. & Mahfouz, A. A. (2013). Rift Valley fever among children and adolescents in southwestern Saudi Arabia. J Infect Public Health 6, 230-235
3. Alazawi, W., Heath, H., Waters, J. A., Woodfin, A., O’Brien, A. J., Scarzello, A. J., Ma, B., Lopez-Otalora, Y., Jacobs, M. & other authors (2013). STAT2 loss leads to cytokine-independent, cellmediated lethality in LPS-induced sepsis. Proc Natl Acad Sci USA 110, 8656-8661
4. Askari, N., Beenstock, J., Livnah, O. & Engelberg, D. (2009). p38alpha is active in vitro and in vivo when monophosphorylated at threonine 180. Biochemistry 48, 2497-2504
5. Austin, D., Baer, A., Lundberg, L., Shafagati, N., Schoonmaker, A., Narayanan, A., Popova, T., Panthier, J. J., Kashanchi, F. & other authors (2012). p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production. PLoS ONE 7, e36327
6. Billecocq, A., Spiegel, M., Vialat, P., Kohl, A., Weber, F., Bouloy, M. & Haller, O. (2004). NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 78, 9798-9806
7. Bird, B. H., Ksiazek, T. G., Nichol, S. T. & Maclachlan, N. J. (2009). Rift Valley fever virus. J Am Vet Med Assoc 234, 883-893
8. Bol, S. M., Booiman, T., Bunnik, E. M., Moerland, P. D., van Dort, K., Strauss, J. F. III, Sieberer, M., Schuitemaker, H., Kootstra, N. A. & van’t Wout, A. B. (2011a). Polymorphism in HIV-1 dependency factor PDE8A affects mRNA level and HIV-1 replication in primary macrophages. Virology 420, 32-42
9. Bol, S. M., Cobos-Jimenez, V., Kootstra, N. A. & van’t Wout, A. B. (2011b). HIV-1 and the macrophage. Future Virology 6, 187-208
10. Bouloy, M., Janzen, C., Vialat, P., Khun, H., Pavlovic, J., Huerre, M. & Haller, O. (2001). Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol 75, 1371-1377
11. Bray, M. & Geisbert, T. W. (2005). Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 37, 1560-1566
12. Cargnello, M. & Roux, P. P. (2011). Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75, 50-83
13. Chia, J. K., Pollack, M., Guelde, G., Koles, N. L., Miller, M. & Evans, M. E. (1989). Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages. J Infect Dis 159, 872-880.
14. Chowdhury, F. Z. & Farrar, J. D. (2013). STAT2: a shape-shifting anti-viral super STAT. JAK-STAT 2, e23633.
15. Cuadrado, A. & Nebreda, A. R. (2010). Mechanisms and functions of p38 MAPK signalling. Biochem J 429, 403-417.
16. Davies, F. G. (2010). The historical and recent impact of Rift Valley fever in Africa. Am J Trop Med Hyg 83, 73-74
17. Davies, F. G. & Martin, V. (editors) (2003). Recognizing Rift Valley Fever. Rome: Food and Agriculture Organization of the United Nations
18. do Valle, T. Z., Billecocq, A., Guillemot, L., Alberts, R., Gommet, C., Geffers, R., Calabrese, K., Schughart, K., Bouloy, M. & other authors (2010). A new mouse model reveals a critical role for host innate immunity in resistance to Rift Valley fever. J Immunol 185, 6146-6156
19. Dupuis-Maguiraga, L., Noret, M., Brun, S., Le Grand, R., Gras, G. & Roques, P. (2012). Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis 6, e1446
20. Ermler, M. E., Traylor, Z., Patel, K., Schattgen, S. A., Vanaja, S. K., Fitzgerald, K. A. & Hise, A. G. (2014). Rift Valley fever virus infection induces activation of the NLRP3 inflammasome. Virology 449, 174-180
21. Findlay, G. M. & Daubney, R. (1931). The virus of Rift Valley Fever or enzootic hepatitis. Lancet 221, 1350-1351
22. Gear, J. H. (1977). Haemorrhagic fevers of Africa: an account of two recent outbreaks. J S Afr Vet Assoc 48, 5-8
23. Gough, D. J., Sabapathy, K., Ko, E. Y., Arthur, H. A., Schreiber, R. D., Trapani, J. A., Clarke, C. J. & Johnstone, R. W. (2007). A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genes. J Biol Chem 282, 938-946
24. Gray, K. K., Worthy, M. N., Juelich, T. L., Agar, S. L., Poussard, A., Ragland, D., Freiberg, A. N. & Holbrook, M. R. (2012). Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. PLoS Negl Trop Dis 6, e1529
25. Head, J. A., Kalveram, B. & Ikegami, T. (2012). Functional analysis of Rift Valley fever virus NSs encoding a partial truncation. PLoS ONE 7, e45730
26. Ikegami, T., Won, S., Peters, C. J. & Makino, S. (2006). Rescue of infectious Rift Valley Fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol 80, 2933-2940
27. Ikegami, T., Narayanan, K., Won, S., Kamitani, W., Peters, C. J. & Makino, S. (2009a). Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and posttranscriptional downregulation of protein kinase PKR. Ann N Y Acad Sci 1171 (Suppl 1), E75-E85
28. Ikegami, T., Narayanan, K., Won, S., Kamitani, W., Peters, C. J. & Makino, S. (2009b). Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog 5, e1000287
29. Jansen van Vuren, P., Tiemessen, C. & Paweska, J. T. (2011). Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice. PLoS ONE 6, e25027
30. Kalveram, B., Lihoradova, O., Indran, S. V. & Ikegami, T. (2011). Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy. J Vis Exp 57, e3400.
31. Kalveram, B., Lihoradova, O., Indran, S. V., Lokugamage, N., Head, J. A. & Ikegami, T. (2013). Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR. Virology 435, 415-424.
32. Kamal, S. A. (2009). Pathological studies on postvaccinal reactions of Rift Valley fever in goats. Virol J 6, 94
33. Kang, Y. J., Seit-Nebi, A., Davis, R. J. & Han, J. (2006). Multiple activation mechanisms of p38alpha mitogen-activated protein kinase. J Biol Chem 281, 26225-26234
34. Kasari, T. R., Carr, D. A., Lynn, T. V. & Weaver, J. T. (2008). Evaluation of pathways for release of Rift Valley fever virus into domestic ruminant livestock, ruminant wildlife, and human populations in the continental United States. J Am Vet Med Assoc 232, 514-529
35. Kawai, T. & Akira, S. (2007). Antiviral signaling through pattern recognition receptors. J Biochem 141, 137-145.
36. Le May, N., Mansuroglu, Z., Léger, P., Josse, T., Blot, G., Billecocq, A., Flick, R., Jacob, Y., Bonnefoy, E. & Bouloy, M. (2008). A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. PLoS Pathog 4, e13.
37. Lewis, R. M., Cosgriff, T. M., Peters, C. J. & Morrill, J. C. (1987). Differentiation of a human monocytic cell line associated with increased production of Rift Valley fever virus by infected cells. J Med Virol 23, 207-215.
38. Lokugamage, N., Freiberg, A. N., Morrill, J. C. & Ikegami, T. (2012). Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains. J Virol 86, 13566-13575
39. Ma, X., Sun, J., Papasavvas, E., Riemann, H., Robertson, S., Marshall, J., Bailer, R. T., Moore, A., Donnelly, R. P. & other authors (2000). Inhibition of IL-12 production in human monocyte-derived macrophages by TNF. J Immunol 164, 1722-1729.
40. Maar, S. A., Swanepoel, R. & Gelfand, M. (1979). Rift Valley fever encephalitis. A description of a case. Cent Afr J Med 25, 8-11.
41. Mapaco, L. P., Coetzer, J. A., Paweska, J. T. & Venter, E. H. (2012). An investigation into an outbreak of Rift Valley fever on a cattle farm in Bela-Bela, South Africa, in 2008. J S Afr Vet Assoc 83, 132
42. McElroy, A. K. & Nichol, S. T. (2012). Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. Virology 422, 6-12
43. Meek, D. W. (2009). Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer 9, 714-723
44. Menendez, D., Shatz, M., Azzam, K., Garantziotis, S., Fessler, M. B. & Resnick, M. A. (2011). The Toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet 7, e1001360
45. Mills, C. D. (2012). M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol 32, 463-488
46. Morrill, J. C., Jennings, G. B., Cosgriff, T. M., Gibbs, P. H. & Peters, C. J. (1989). Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. Rev Infect Dis 11 (Suppl 4), S815-S825.
47. Morrill, J. C., Jennings, G. B., Johnson, A. J., Cosgriff, T. M., Gibbs, P. H. & Peters, C. J. (1990). Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response. Arch Virol 110, 195-212.
48. Morrill, J. C., Czarniecki, C. W. & Peters, C. J. (1991). Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey. J Interferon Res 11, 297-304.
49. Narayanan, A., Popova, T., Turell, M., Kidd, J., Chertow, J., Popov, S. G., Bailey, C., Kashanchi, F. & Kehn-Hall, K. (2011). Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection. PLoS ONE 6, e20354.
50. Pan, C. H., Kim, E. S., Jung, S. H., Nho, C. W. & Lee, J. K. (2008). Tectorigenin inhibits IFN-gamma/LPS-induced inflammatory responses in murine macrophage RAW 264.7 cells. Arch Pharm Res 31, 1447-1456
51. Remy, G., Risco, A. M., Iñesta-Vaquera, F. A., González-Terán, B., Sabio, G., Davis, R. J. & Cuenda, A. (2010). Differential activation of p38MAPK isoforms by MKK6 and MKK3. Cell Signal 22, 660-667.
52. Schoenborn, J. R. & Wilson, C. B. (2007). Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96, 41-101.
53. Schwentker, F. F. & Rivers, T. M. (1934). Rift Valley fever in man: report of a fatal laboratory infection complicated by thrombophlebitis. J Exp Med 59, 305-313.
54. Shieh, W. J., Paddock, C. D., Lederman, E., Rao, C. Y., Gould, L. H., Mohamed, M., Mosha, F., Mghamba, J., Bloland, P. & other authors (2010). Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006-2007. Am J Trop Med Hyg 83 (Suppl), 38-42
55. Smith, D. R., Steele, K. E., Shamblin, J., Honko, A., Johnson, J., Reed, C., Kennedy, M., Chapman, J. L. & Hensley, L. E. (2010). The pathogenesis of Rift Valley fever virus in the mouse model. Virology 407, 256-267
56. Swanepoel, R. & Coetzer, J. A. W. (1994). Rift Valley fever. In Infectious Diseases of Livestock, Vol. I pp. 688-717. Edited by J. A. W. Coetzer, G. R. Thomson & R. C. Tustin. New York: Oxford University Press
57. Swanepoel, R. & Coetzer, J. A. W. (2004). Rift Valley fever. In Infectious Diseases of Livestock, 2nd edn, pp. 1038-1070. Edited by J. A. W. Coetzer & R. C. Tustin. Cape Town: Oxford University Press
58. Tugal, D., Liao, X. & Jain, M. K. (2013). Transcriptional control of macrophage polarization. Arterioscler Thromb Vasc Biol 33, 1135-1144.
59. Yi, P. F., Bi, W. Y., Shen, H. Q., Wei, Q., Zhang, L. Y., Dong, H. B., Bai, H. L., Zhang, C., Song, Z. & other authors (2013). Inhibitory effects of sulfated 20(S)-ginsenoside Rh2 on the release of pro-inflammatory mediators in LPS-induced RAW 264.7 cells. Eur J Pharmacol 712, 60-66.